These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31047739)

  • 1. Use of Eovist in Pediatric Patients: Pearls and Pitfalls.
    Shet NS; Flynn JF; Maloney E; Iyer RS
    Curr Probl Diagn Radiol; 2020; 49(4):266-274. PubMed ID: 31047739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does intravenous administration of gadoxetate disodium have any effect on breath-hold times.
    Bergmann K; Agris J; Balzer T
    Radiology; 2013 Sep; 268(3):926-7. PubMed ID: 23970514
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of acute transient dyspnea after intravenous administration of gadoxetate disodium and gadobenate dimeglumine: effect on arterial phase image quality.
    Davenport MS; Viglianti BL; Al-Hawary MM; Caoili EM; Kaza RK; Liu PS; Maturen KE; Chenevert TL; Hussain HK
    Radiology; 2013 Feb; 266(2):452-61. PubMed ID: 23192781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rate of gadoxetate disodium (Eovist®) induced transient respiratory motion in children and young adults.
    Lanier H; Wallace A; Khanna G
    Abdom Radiol (NY); 2020 Jan; 45(1):101-106. PubMed ID: 31701191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical use and pitfalls of hepatocyte-specific contrast agents (HSCAs) for pediatric hepatic and biliary magnetic resonance imaging.
    Ayyala RS; Anupindi SA; Callahan MJ
    Abdom Radiol (NY); 2017 Feb; 42(2):502-520. PubMed ID: 27680015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadoxetate Disodium versus Gadoterate Meglumine: Quantitative Respiratory and Hemodynamic Metrics by Using Compressed-Sensing MRI.
    Glessgen CG; Moor M; Stieltjes B; Winkel DJ; Block TK; Merkle EM; Heye TJ; Boll DT
    Radiology; 2019 Nov; 293(2):317-326. PubMed ID: 31549944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Pictorial Review of Hepatobiliary Magnetic Resonance Imaging With Hepatocyte-Specific Contrast Agents: Uses, Findings, and Pitfalls of Gadoxetate Disodium and Gadobenate Dimeglumine.
    Scali EP; Walshe T; Tiwari HA; Harris AC; Chang SD
    Can Assoc Radiol J; 2017 Aug; 68(3):293-307. PubMed ID: 28583364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of pediatric liver lesions with gadoxetate disodium.
    Meyers AB; Towbin AJ; Serai S; Geller JI; Podberesky DJ
    Pediatr Radiol; 2011 Sep; 41(9):1183-97. PubMed ID: 21701987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gadoxetate disodium-induced tachypnoea and the effect of dilution method: a proof-of-concept study in mice.
    Akai H; Yasaka K; Nojima M; Kunimatsu A; Inoue Y; Abe O; Ohtomo K; Kiryu S
    Eur Radiol; 2018 Feb; 28(2):692-697. PubMed ID: 28894937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Gadoxetate Disodium on Arterial Phase Respiratory Waveforms Using a Quantitative Fast Fourier Transformation-Based Analysis.
    Davenport MS; Malyarenko DI; Pang Y; Hussain HK; Chenevert TL
    AJR Am J Roentgenol; 2017 Feb; 208(2):328-336. PubMed ID: 27929673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory motion in children and young adults undergoing liver magnetic resonance imaging with intravenous gadoxetate disodium contrast material.
    Gilligan LA; Trout AT; Anton CG; Schapiro AH; Towbin AJ; Dillman JR
    Pediatr Radiol; 2019 Aug; 49(9):1171-1176. PubMed ID: 31203405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging findings of primary hepatic angiosarcoma on gadoxetate disodium-enhanced liver MRI: comparison with hepatic haemangiomas of similar size.
    Kim B; Byun JH; Lee JH; Park BJ; Kwon HJ; Lee JH; Lee SJ; Won HJ; Shin YM; Kim PN
    Clin Radiol; 2018 Mar; 73(3):244-253. PubMed ID: 29111237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gadoxetate disodium in patients with primary sclerosing cholangitis: an analysis of hepatobiliary contrast excretion.
    Ringe KI; Hinrichs J; Merkle EM; Weismüller TJ; Wacker F; Meyer BC
    J Magn Reson Imaging; 2014 Jul; 40(1):106-12. PubMed ID: 24923477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response.
    Davenport MS; Liu PS; Chenevert TL; Hussain HK
    Radiology; 2013 Sep; 268(3):927. PubMed ID: 24137709
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of intravenous gadoxetate disodium and flip angle on hepatic proton density fat fraction estimation with six-echo, gradient-recalled-echo, magnitude-based MR imaging at 3T.
    Park CC; Hamilton G; Desai A; Zand KA; Wolfson T; Hooker JC; Costa E; Heba E; Clark L; Gamst A; Loomba R; Middleton MS; Sirlin CB
    Abdom Radiol (NY); 2017 Apr; 42(4):1189-1198. PubMed ID: 28028556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-toxicity relationship of gadoxetate disodium and transient severe respiratory motion artifact.
    Davenport MS; Bashir MR; Pietryga JA; Weber JT; Khalatbari S; Hussain HK
    AJR Am J Roentgenol; 2014 Oct; 203(4):796-802. PubMed ID: 25055154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary experience with intravenous gadoxetate disodium as a craniospinal MR contrast agent.
    McKinney AM; Gawande R; Pezeshk P; Truwit CL; Rykken JB
    Eur J Radiol; 2015 Dec; 84(12):2539-47. PubMed ID: 26456308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrogenic systemic fibrosis risk after liver magnetic resonance imaging with gadoxetate disodium in patients with moderate to severe renal impairment: results of a prospective, open-label, multicenter study.
    Lauenstein T; Ramirez-Garrido F; Kim YH; Rha SE; Ricke J; Phongkitkarun S; Boettcher J; Gupta RT; Korpraphong P; Tanomkiat W; Furtner J; Liu PS; Henry M; Endrikat J
    Invest Radiol; 2015 Jun; 50(6):416-22. PubMed ID: 25756684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A word of caution on the use of high-dose MR contrast media in patients with renal failure.
    Geckeis K; Eggebrecht H; Quick HH; Barkhausen J; Kribben A; Erbel R
    J Endovasc Ther; 2005 Apr; 12(2):262. PubMed ID: 15823076
    [No Abstract]   [Full Text] [Related]  

  • 20. Pediatric Patients Demonstrate Progressive T1-Weighted Hyperintensity in the Dentate Nucleus following Multiple Doses of Gadolinium-Based Contrast Agent.
    Roberts DR; Chatterjee AR; Yazdani M; Marebwa B; Brown T; Collins H; Bolles G; Jenrette JM; Nietert PJ; Zhu X
    AJNR Am J Neuroradiol; 2016 Dec; 37(12):2340-2347. PubMed ID: 27469211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.